Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 16, 1996

View Archived Issues

New antihypertensive agents from Banyu

Distamycin analogues claimed by Mitsui Toatsu

New antitussive agent from Snow Brand Milk Products

Antiinflammatory glycolipid compounds from Nissin Food Products

Antiallergic/antiasthmatic compounds disclosed by Dainippon Ink

Eisai describes selective dopamine D3 antagonists

Novel anticancer agents from Sankyo

Toray reports peptides for toxic shock syndrome

British Biotech reports new MMP inhibitors

New ET-1 inhibitors from Ciba-Geigy

Scotia files EF27

University of Alberta discovers new chemokine-binding protein

Neurogen and Pfizer extend GABA-based collaboration

Affymax researches potential malaria vaccines

LXR Biotechnology/Boehringer Mannheim enter breast and prostate cancer collaboration

Oncor expands marketing of breast cancer test

SKB reports new vaccine compositions

Human growth hormone products recommended for approval

Advanced Polymer Systems to supply Johnson & Johnson with Microsponge-entrapped AHAs

New antisense compounds reported by French investigators

Alanex and Novo Nordisk expand diabetes research collaboration

MedImmune files IND for HPV vaccine candidate

New bile acid transporter inhibitors in preclinical testing at Searle

Acea describes candidate neuroprotectant

Glaxo Wellcome granted license to Cellegy orphan drug

Oncogene Science and Bayer initiate cancer diagnostics collaboration

CRC and Cortecs to develop cancer diagnostic tests

Terrapin Technologies obtains rights to Walter Reed compound library

Epic receives patent coverage for core drug delivery technology

Celox Laboratories' ViaStem receives patent coverage

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...